Choose your language:

Facebook
LinkedIn
Twitter
Providing Capital & Management Solutions for Private & Public Companies and Sophisticated Investors

Fyi Resources Limited (Fyi) Receives First Funds (AU$3.13m) From AU$80m International Fund Arranged By Bluemount Capital (WA)

Key Points

  • International fund takes initial stake in FYI with $3.13m opening investment.
  • BlueMount Capital (WA) arranged $80m facility for FYI.
  • Strategic investment directed at progressing development of FYI High Purity Alumina
    (HPA) project.
  • Placement provides long term major shareholder support.

BlueMount Capital is pleased to announce FYI will receive the first investment from the $80m equity facility it arranged for FYI, with an initial placement of $3.13m. FYI is listed on the Australian Securities Exchange (ASX code: FYI).
The placement of $3.13m is via an issue of 9.3 million shares at a price of 33.67 cents each calculated according to the terms of the capital commitment facility, under FYI’s current ASX Listing Rule 7.1A placement capacity to raise gross proceeds of $3,131,310. Continue reading

Altech – Listed Green Bond Preparations Progressing Well

Highlights

  • Listed green bond targeting an offer of ~US$144m
  • Preparation progressing well and on track
  • HPA project 49% less carbon footprint than conventional HPA

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) (FRA: A3Y) is pleased to advise that preparations for its proposed listed green bond offering of ~US$144 million, to provide additional financing for its Malaysian high purity alumina (HPA) project are on track and progressing well. Continue reading

Technology and International Stock Exchange Listings for US companies

An IPO is often the most important capital markets and wealth creation event in a corporate life cycle. Unmatched access to capital at a lower cost is a clear benefit in favour of an IPO, along with corporate branding opportunities and a host of other benefits.

Companies consider three things when choosing a listing location—the actual out-of-pocket costs for establishing and maintaining the listing, the effects on valuation and liquidity, and the nonfinancial benefits. Continue reading

Healthcare and International Stock Exchange Listings for US companies

An IPO is often the most important capital markets and wealth creation event in your corporate life cycle. Unmatched access to capital at a lower cost is a clear benefit in favour of an IPO, along with corporate branding opportunities and a host of other benefits.

Your company should consider three things when choosing a listing location—the actual out-of-pocket costs for establishing and maintaining the listing, the effects on valuation and liquidity, and the nonfinancial benefits. (A fuller discussion of the pros and cons of listing on the Australian Securities Exchange (ASX) versus the Nasdaq or NYSE can be found in the second of this series of BlueMount Capital’s articles: “International Stock Exchange Listings for US Companies”.) Continue reading

International Stock Exchange Listing – Alternatives for US companies

In the past five years there has been a marked increase in the number of international companies listing on the Australian Securities Exchange (ASX). Why is this happening? What are the thought processes and market dynamics that attracted these companies to list on the ASX? Where these companies are U.S. based, what were the factors that stimulated them to look outside their home capital markets? Are the experiences of these companies relevant to your own capital raising considerations? Continue reading

IPO in the United States? Remember, size matters!

Is your company large enough to IPO in the United States (U.S.)?

You know that when choosing a listing location three things should be considered

(1) the actual out-of-pocket costs for establishing and maintaining the listing;

(2) the effects of a listing location on your company’s valuation and liquidity; and

(3) the non-financial costs and benefits that are available in a particular listing location. Continue reading

BlueMount Capital Opens Los Angeles USA Office – Focus on Listing US Tech Firms on ASX

Sydney, Australia. BlueMount Capital, an ASIC licensed, mid-tier, global investment banking and corporate advisory group headquartered in Australia has today opened an office in Los Angeles and appointed Alex Chen as our representative there.

Alex has over 25 years’ experience in the financial services sector. He has served as CFO for both public and private companies in Australia, Hong Kong, China and the United States and as CEO across a wide spectrum of industries. He specializes in the Pacific Region with a focus in USA IPO’s, where he has significant experience. He is a CPA with a Bachelor of Commerce from Victoria University in Australia and is licensed as a USA investment banker. Alex is bilingual and fluent in English and Mandarin. Continue reading

Altech Chemicals Ltd (ASX:ATC) Initiates Listed Green Bond Project Funding Option

Perth, Australia, Aug 20, 2020 – (ABN Newswire) – Altech Chemicals Limited (ASX:ATC) (HAM:A3Y) is pleased to announce that it has initiated a listed green bond project funding option. The Company has mandated Bluemount Capital (WA) Pty Ltd (Bluemount), which will work in conjunction with its London based partner Bedford Row Capital (Bedford), as structuring agent, to prepare a Bond Structuring and Execution Plan for an offering of asset-backed (second lien) listed “green” bonds to the European bond market.

Continue reading

Social Islami Bank Limited engages Australia-based BlueMount Capital for issuing an international sukuk

Social Islami Bank Limited and Australia based Investment Bank BlueMount Capital signed a Mandate Agreement on 15th March 2020 at the Head Office of SIBL. Under the scope of the Agreement, BlueMount Capital will act as the International Lead Manager in placing an international sukuk for USD 75 million for SIBL within the regulatory framework of Bangladesh. Mr. Quazi Osman Ali, Managing Director & CEO, and other high officials from SlBL were present at the signing ceremony. Local representatives of BlueMount Capital exchanged the Agreement on behalf of their organization.

BlueMount Capital is the International Lead Manager for the issuance of a US$75 million Sukuk by Social Islami Bank Limited (“SIBL” or the “Bank”) in international markets.

The funds raised under the Sukuk will be used by SIBL to comply with the capital adequacy requirements of Basel III and for working capital purposes.

About Social Islami Bank Limited

SIBL is a commercial bank in Bangladesh listed on the Dhaka Stock Exchange. The Bank was founded in 1995 and operates on Shariah Principles. SIBL has more than 3,300 employees and operates 161 branches and 27 sub-branches that are complemented by 115 Agent Banking outlets. The Bank’s mission is to become the Country’s most humanitarian, full-service bank that builds solid, long term business relationships with its customers and helps them with their banking needs. The Bank’s social and economic objectives are to create a caring society and to help eradicate poverty and to empower families.

SIBL has experienced good growth in business with deposits increasing from US$527.7 million in 2010 to $2.92 billion in 2018, whilst investments grew from $431.5 million to $2.8 billion over the same time. The business growth is reflected in growth in operating profits and net profit after tax. The Bank has a Moody’s credit rating of Long Term B1 and Short-Term NP, Stable.